IndiaOne Finance - Company Dashboard

Governance Classic Home

Kwality Pharmaceuticals LtdPharmaceuticalsINE552U01010Standalone₹3475.40+24.05 (+0.70%)Jun-26

Valuation

Market Cap₹3.61K Cr

TTM PE44.50x

Forward PE40.41x

PEG0.96

Book Value₹254.48

P/B13.66x

TTM EPS₹78.10

Fwd EPS₹86.00

TTM Revenue₹553.93 Cr

TTM PAT₹81.05 Cr

TTM EBITDA₹135.07 Cr

TTM EBIT₹115.04 Cr

Last Qtr PAT₹25.63 Cr

Last Qtr EBITDA₹41.02 Cr

Last Qtr EBIT₹36.03 Cr

Profitability

ROE30.69%

ROCE31.00%

TTM NPM14.63%

TTM EBITDA %24.38%

Curr OPM15.78%

Last OPM16.13%

Curr NPM—

Last NPM—

Curr EPS₹24.70

Last EPS₹24.37

Balance sheet

Equity₹10.38 Cr

Reserve₹253.67 Cr

Total Debt₹112.45 Cr

D/E0.43x

Interest %10.38%

Curr Interest₹2.66 Cr

Price / range

Close₹3475.40

vs 52W High-7.84%

vs 52W Low+319.33%

MA50—

MA200—

Returns

1D+0.70%

1W-4.59%

1M-1.52%

3M+48.11%

6M+122.26%

1Y+251.25%

2Y+334.59%

3Y+814.82%

5Y+456.06%

Diwali+208.60%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	162.35+45.6%	156.82	123.45	111.31	111.48	503.06
Other Income	0.62	1.06	0.53	0.90	0.38	2.86
Total Income	162.98+45.7%	157.88	123.97	112.21	111.86	505.92
Interest	2.66	2.89	2.48	2.84	2.76	10.97
Expenditure	-128.98-36.1%	-126.23	-100.79	-93.76	-94.80	-415.60
PBDT	0	0	0	0	0	0
EBITDA	41.02+69.5%	38.74	29.96	25.35	24.20	118.22
Depreciation	-4.99	-5.26	-4.82	-4.96	-4.76	-19.79
EBIT	36.03+85.3%	33.48	25.14	20.39	19.44	98.43
PBT	33.99+99.5%	31.65	22.35	18.45	17.04	89.49
Tax	-8.37	-6.36	-6.35	-4.34	-5.10	-22.15
Equity	0	0	0	0	0	0
OPM	20.94	20.18	18.11	16.58	15.29	18.00
Net Profit	25.63+114.8%	25.29	16.01	14.12	11.93	67.35
NPM	15.78	16.13	12.97	12.68	10.70	13.00
EPS	24.70	24.37	15.43	13.60	0	64.90

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 16-17
Revenue	503.06+35.9%	370.20+20.5%	307.17	95.32
Other Income	2.86	1.92	1.83	1.52
Total Income	505.92+36.0%	372.12+20.4%	309	96.84
Expenditure	-415.60-30.7%	-317.89-17.5%	-270.44	-88.66
Interest	-10.97	-9.88	-10.39	-1.88
PBDT	0	0	0	8.18
EBITDA	118.22+46.9%	80.45+20.7%	66.63	10.91
Depreciation	-19.79	-18.26	-19.51	-2.37
EBIT	98.43+58.3%	62.19+32.0%	47.12	8.54
PBT	89.49+65.0%	54.23+72.3%	31.47	5.81
Tax	-22.15	-14.34	-7.48	-2.37
Equity	0	10.38	0	5.19
OPM (%)	18.00	14.57	10.00	8.58
Net Profit	67.35+68.8%	39.89+66.3%	23.98	3.44
NPM (%)	13.00	10.72	8.00	3.61
EPS (Rs)	64.90+68.8%	38.44+66.3%	23.11	6.70
CEPS	64.90	38.44	23.11	11.20

Metric	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	FY24-25
Revenue	123.44+46.2%	111.05	111.48	115.68	84.41	370.20
Other Income	0.53	0.90	0.38	0.77	0.66	1.92
Total Income	123.97+45.7%	111.95	111.86	116.44	85.06	372.12
Interest	0	2.84	2.76	2.49	2.20	9.88
Expenditure	-100.79-36.8%	-93.50	-94.80	-97.30	-73.67	-317.98
PBDT	0	0	0	0	0	0
EBITDA	22.65+29.4%	25.35	24.21	25.96	17.50	80.39
Depreciation	0	-4.96	-4.77	-5.09	-4.56	-18.29
EBIT	22.65+75.0%	20.39	19.44	20.87	12.94	62.10
PBT	22.35+96.2%	18.45	17.03	19.08	11.39	54.14
Tax	-6.35	-4.34	-5.10	-4.50	-2.87	-14.34
Equity	0	0	0	0	0	10.38
OPM	18.02	16.48	15.22	16.38	13.39	14.55
Net Profit	16+87.8%	14.12	11.92	14.48	8.52	39.80
NPM	12.91	12.61	10.66	12.44	10.02	10.70
EPS	0-100.0%	13.60	11.49	13.95	8.21	38.36

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 24-25	FY 23-24
Revenue	370.20+20.5%	307.17
Other Income	1.92	1.83
Total Income	372.12+20.4%	309
Expenditure	-317.98-17.4%	-270.80
Interest	-9.88	-10.39
PBDT	0	0
EBITDA	80.39+21.2%	66.32
Depreciation	-18.29	-19.56
EBIT	62.10+32.8%	46.76
PBT	54.14+74.1%	31.10
Tax	-14.34	-7.48
Equity	10.38	0
OPM (%)	14.55	10.06
Net Profit	39.80+68.5%	23.62
NPM (%)	10.70	7.64
EPS (Rs)	38.36+68.5%	22.76
CEPS	38.36	22.76

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2017	Interim Dividend	0.6	05 Jan 2017

Bonus

Year	Ratio	Ex-Date
2017	1:1	11 Oct 2017

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split